SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1FD1FE12BF491EE35CD6C8C72B966C650DE4307ED37FDB614369D584BD7ABD4EC908529DCC65558945C21B96874D2A6F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1FD1FE12BF491EE35CD6C8C72B966C650DE4307ED37FDB614369D584BD7ABD4EC908529DCC65558945C21B96874D2A6F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1FD1FE12BF491EE35CD6C8C72B966C650DE4307ED37FDB614369D584BD7ABD4EC908529DCC65558945C21B96874D2A6F
http://www.w3.org/2000/01/rdf-schema#comment
"Beneficial role for PPARgamma-specific ligands in the treatment of hypertension. Therapeutic strategies targeting endothelial cells may prove useful."
xsd:string
http://purl.uniprot.org/uniprot/#_FABF0DB3878D605BBA22BCB871805D9AC589C07D986E125DA8C10593346B42A4FABFB34062FF5967C0970BBBC7CB0012
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1FD1FE12BF491EE35CD6C8C72B966C650DE4307ED37FDB614369D584BD7ABD4EC908529DCC65558945C21B96874D2A6F
http://purl.uniprot.org/uniprot/Q6TQE4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1FD1FE12BF491EE35CD6C8C72B966C650DE4307ED37FDB614369D584BD7ABD4EC908529DCC65558945C21B96874D2A6F
http://purl.uniprot.org/uniprot/#_Q6TQE4-mappedCitation-15831367
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1FD1FE12BF491EE35CD6C8C72B966C650DE4307ED37FDB614369D584BD7ABD4EC908529DCC65558945C21B96874D2A6F